Renibus Therapeutics Announces Oral Presentation on Phase 3 PROTECT Trial Data for RBT-1 at the American Association for Thoracic Surgery (AATS) Annual Meeting Clinical study in cardiac surgery patients demonstrates favorable safety profile; exploratory analyses suggest potential benefit in higher-risk populations Southlake, Texas, April 30, 2026 (PR NEWSWIRE) – Renibus Therapeutics® (“Renibus”), a […] The post Renibus Therapeutics Announces Oral Presentation on Phase 3 PROTECT Trial Data for RBT-1 at the American Association for Thoracic Surgery (AATS) Annual Meeting appeared first on Renib